Global Canine Arthritis Treatment Market
Veterinary Healthcare

Canine Arthritis Treatment Forecast Report – Designed for Decision Makers and Product Teams

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Canine Arthritis Treatment Market In 2029?

Over the past few years, there has been significant growth in the market size for canine arthritis treatment. The market is projected to expand from $2.35 billion in 2024 to $2.48 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include the ageing pet population, heightened awareness among pet owners, emphasis on preventive care, boosted disposable income, and a rise in the expenditure on veterinary care.

What Growth Rate Is Forecasted for the Canine Arthritis Treatment Market by 2029?

The anticipated growth of the canine arthritis treatment market is strong for the coming years, with a predicted size of $3.06 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.4%. A surge in pet insurance coverage, an increase in arthritis cases, a rise in the number of pet owners, the demand for minimally invasive surgeries, along with the growing occurrence of arthritis in dogs are key factors propelling this growth during the projected period. The market trends during this time are anticipated to be innovations in treatment, advancements in veterinary medicine, a requirement for advanced therapies, the incorporation of technology, and novel technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

Which Key Companies Are Shaping the Future of the Canine Arthritis Treatment Market?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Which Factors Are Driving Demand in the Canine Arthritis Treatment Industry?

The growth of the canine arthritis treatment market is poised to be driven by the increasing rate of pet ownership. The concept of pet ownership entails the obligation and care provided by individuals or families to attend to the necessities, well-being, and companionship of domesticated animals that are primarily kept for enjoyment rather than utility. The upward trend in pet ownership is attributed to factors such as changes in lifestyle, the anthropomorphization of pets, and elevated disposable incomes. Pet owners employ treatments for canine arthritis to manage and lessen the symptoms of arthritis in their dogs with the goal of enhancing their pets’ quality of life and preserving mobility. For example, in October 2023, the American Pet Products Association, a non-profit association based in the US, reported that there were 86.9 million US households with a pet, accounting for 66% of households in 2022. Consequently, the escalating rate of pet ownership is fueling the expansion of the canine arthritis treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

How Is the Canine Arthritis Treatment Market Segmented by Several Divisions?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

What are the Emerging Market Trends Driving the Growth of the Canine Arthritis Treatment Industry?

Top players in the canine arthritis treatment market are pioneering novel therapies, such as bedinvetmab injections, to tackle issues related to dog joint health and mobility. Bedinvetmab, a monoclonal antibody injection, operates by identifying and neutralizing nerve growth factor (NGF), a pain-related protein utilized in veterinary medicine. For example, Zoetis Inc., an American animal health firm, in May 2023 gained approval from the Food and Drug Administration (FDA) for Librela, an injection of bedinvetmab. This is the first-ever monoclonal antibody (mAb) receiving FDA’s sanction for usage in dogs and it functions by binding and suppressing the biological function of canine nerve growth factor (NGF), which plays a key role in managing pain associated with OA. It can be given via a subcutaneous injection every month, marking it as a handy and enduring solution for managing the pain of canine OA.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Which Regions Are Driving Growth in the Canine Arthritis Treatment Market?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

This Report Delivers Insight On:

1. How big is the canine arthritis treatment market, and how is it changing globally?

2. Who are the major companies in the canine arthritis treatment market, and how are they performing?

3. What are the key opportunities and risks in the canine arthritis treatment market right now?

4. Which products or customer segments are growing the most in the canine arthritis treatment market?

5. What factors are helping or slowing down the growth of the canine arthritis treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model